These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 11851358)
21. Pharmacological preconditioning by levosimendan is mediated by inducible nitric oxide synthase and mitochondrial KATP channel activation in the in vivo anesthetized rabbit heart model. Das B; Sarkar C Vascul Pharmacol; 2007 Oct; 47(4):248-56. PubMed ID: 17728191 [TBL] [Abstract][Full Text] [Related]
22. Nitric oxide as a mediator of delayed pharmacological (A(1) receptor triggered) preconditioning; is eNOS masquerading as iNOS? Bell RM; Smith CC; Yellon DM Cardiovasc Res; 2002 Feb; 53(2):405-13. PubMed ID: 11827691 [TBL] [Abstract][Full Text] [Related]
23. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839 [TBL] [Abstract][Full Text] [Related]
24. Ethanol induced delayed cellular protection in mouse cardiac myocytes: role of inducible nitric oxide synthase. Nayeem MA Pol J Pharmacol; 2003; 55(4):595-602. PubMed ID: 14581718 [TBL] [Abstract][Full Text] [Related]
25. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice. Xi L; Jarrett NC; Hess ML; Kukreja RC Circulation; 1999 Apr; 99(16):2157-63. PubMed ID: 10217657 [TBL] [Abstract][Full Text] [Related]
26. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1. Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023 [TBL] [Abstract][Full Text] [Related]
27. Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo: evidence from pharmacologic inhibition and gene-knockout mice. Jiang X; Shi E; Nakajima Y; Sato S Anesthesiology; 2004 Jul; 101(1):82-8. PubMed ID: 15220775 [TBL] [Abstract][Full Text] [Related]
28. Heightened alpha1A-adrenergic receptor activity suppresses ischaemia/reperfusion-induced Ins(1,4,5)P3 generation in the mouse heart: a comparison with ischaemic preconditioning. Amirahmadi F; Turnbull L; Du XJ; Graham RM; Woodcock EA Clin Sci (Lond); 2008 Jan; 114(2):157-64. PubMed ID: 17696883 [TBL] [Abstract][Full Text] [Related]
29. Expression of active alpha(1B)-adrenergic receptors in the heart does not alleviate ischemic reperfusion injury. Gao XM; Wang BH; Woodcock E; Du XJ J Mol Cell Cardiol; 2000 Sep; 32(9):1679-86. PubMed ID: 10966830 [TBL] [Abstract][Full Text] [Related]
30. Activation of alpha 1-adrenoceptors is not essential for the mediation of ischaemic preconditioning in rat heart. Vasara E; Seraskeris S; Lazou A Clin Exp Pharmacol Physiol; 2002; 29(1-2):11-7. PubMed ID: 11906456 [TBL] [Abstract][Full Text] [Related]
31. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. Bolli R J Mol Cell Cardiol; 2001 Nov; 33(11):1897-918. PubMed ID: 11708836 [TBL] [Abstract][Full Text] [Related]
32. Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice. Xi L; Salloum F; Tekin D; Jarrett NC; Kukreja RC Am J Physiol; 1999 Dec; 277(6):H2418-24. PubMed ID: 10600864 [TBL] [Abstract][Full Text] [Related]
33. Pivotal role of nitric oxide in delayed pharmacological preconditioning against myocardial infarction. Xi L; Kukreja RC Toxicology; 2000 Nov; 155(1-3):37-44. PubMed ID: 11154795 [TBL] [Abstract][Full Text] [Related]
34. Expression of genes related to oxidative/nitrosative stress in mouse hearts: effect of preconditioning and cholesterol diet. Kocsis GF; Csont T; Varga-Orvos Z; Puskas LG; Murlasits Z; Ferdinandy P Med Sci Monit; 2010 Jan; 16(1):BR32-9. PubMed ID: 20037483 [TBL] [Abstract][Full Text] [Related]
35. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Guo Y; Jones WK; Xuan YT; Tang XL; Bao W; Wu WJ; Han H; Laubach VE; Ping P; Yang Z; Qiu Y; Bolli R Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11507-12. PubMed ID: 10500207 [TBL] [Abstract][Full Text] [Related]
36. Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia. Xi L; Tekin D; Gursoy E; Salloum F; Levasseur JE; Kukreja RC Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H5-12. PubMed ID: 12063268 [TBL] [Abstract][Full Text] [Related]
37. Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1alpha and AP-1 and iNOS signaling. Xi L; Taher M; Yin C; Salloum F; Kukreja RC Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2369-75. PubMed ID: 15284066 [TBL] [Abstract][Full Text] [Related]
39. COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism. Jiang X; Shi E; Nakajima Y; Sato S Life Sci; 2006 Apr; 78(22):2543-9. PubMed ID: 16325209 [TBL] [Abstract][Full Text] [Related]
40. Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase. Wang YP; Sato C; Mizoguchi K; Yamashita Y; Oe M; Maeta H Cardiovasc Res; 2002 Oct; 56(1):33-42. PubMed ID: 12237164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]